Multi-Agency Informational Meeting Concerning Compliance With the Federal Select Agent Program; Public Webcast, 56845-56846 [2012-22653]

Download as PDF 56845 Federal Register / Vol. 77, No. 179 / Friday, September 14, 2012 / Notices the corresponding dollar amounts. These forms are needed to provide borrowers with information on the cost of their loan(s) and to determine which lenders may have excessive delinquencies and defaulted loans. Number of respondents Instrument Responses per respondent The annual estimate of burden is as follows: Total responses Hours per response Total burden hours Disclosure: Repayment Schedule HRSA 502–1, 2 ............. Reporting: Call Report HRSA 512 ....................................... 7 15 50 4 350 60 .50 .75 175 45 Total Reporting and Disclosure .................................... 22 ........................ 410 ........................ 220 Email comments to paperwork@hrsa.gov, or mail the HRSA Reports Clearance Officer, Room 10–29, Parklawn Building, 5600 Fishers Lane, Rockville, MD 20857. Written comments should be received within 60 days of this notice. Dated: September 10, 2012. Bahar Niakan, Director, Division of Policy and Information Coordination. [FR Doc. 2012–22707 Filed 9–13–12; 8:45 am] BILLING CODE 4165–15–P Centers for Disease Control and Prevention Meeting of the Community Preventive Services Task Force (Task Force) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: The Centers for Disease Control and Prevention (CDC) announces the next meeting of the Community Preventive Services Task Force (Task Force). The Task Force is independent and nonfederal. Its members are nationally known leaders in public health practice, policy, and research, and are appointed by the CDC Director. The Task Force was convened in 1996 by the Department of Health and Human Services (HHS) to assess the effectiveness of community, environmental, population, and healthcare system interventions in public health and health promotion. During this meeting, the Task Force will consider the findings of systematic reviews and issue recommendations and findings to help inform decision making about policy, practice, and research in a wide range of U.S. settings. The Task Force’s recommendations, along with the systematic reviews of the scientific evidence on which they are based, are compiled in the Guide to Community Preventive Services (Community Guide). mstockstill on DSK4VPTVN1PROD with NOTICES VerDate Mar<15>2010 16:39 Sep 13, 2012 Jkt 226001 DEPARTMENT OF HEALTH AND HUMAN SERVICES The Task Force Meeting will be held at the Emory Conference Center at 1615 Clifton Road, Atlanta, GA 30329. Information regarding logistics will be available on the Community Guide Web site (www. thecommunityguide.org), Wednesday, September 12, 2012. Multi-Agency Informational Meeting Concerning Compliance With the Federal Select Agent Program; Public Webcast ADDRESSES: FOR FURTHER INFORMATION CONTACT: DEPARTMENT OF HEALTH AND HUMAN SERVICES SUMMARY: The meeting will be held on Wednesday, October 10, 2012 from 8:30 a.m. to 5:30 p.m., EST and Thursday, October 11, 2012 from 8:30 a.m. to 1 p.m. EST. DATES: Allyson Brown, The Community Guide Branch, Epidemiology and Analysis Program Office, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, 1600 Clifton Road, MS–E– 69, Atlanta, Georgia 30333, phone: (404) 498–0937), email: CPSTF@cdc.gov. Purpose: The purpose of the meeting is for the Task Force to consider the findings of systematic reviews and issue recommendations and findings to help inform decision making about policy, practice, and research in a wide range of U.S. settings. Matters To Be Discussed: Matters to be discussed: Tobacco, oral health and cardiovascular disease. Meeting Accessibility: This meeting is open to the public, limited only by space availability. Dated: September 10, 2012. Tanja Popovic, Deputy Associate Director for Science, Centers for Disease Control and Prevention. [FR Doc. 2012–22654 Filed 9–13–12; 8:45 am] BILLING CODE 4163–18–P PO 00000 Centers for Disease Control and Prevention Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of public webcast. AGENCY: The Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HHS) announces the notice of a public webcast concerning compliance with the Federal Select Agent Program. The purpose of this notice is to notify all interested parties, including individuals and entities possessing, using, or transferring biological agents and toxins listed in 7 CFR 331.3, 9 CFR 121.3 and 121.4, or 42 CFR 73.3 and 73.4, of the webcast. The webcast is organized by the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (USDA/APHIS), the Department of Health and Human Services Centers for Disease Control and Prevention (HHS/CDC), and the Department of Justice’s Federal Bureau of Investigation (FBI). Issues to be discussed include changes to the select agent regulations; occupational health, information and physical security; personnel suitability; Bioterrorism Security Risk Assessment Form (FD–961 form); and changes to the Application for Laboratory Registration for Possession, Use, and Transfer of Select Agents and Toxins (APHIS/CDC Form 1). SUMMARY: The webcast will be held on Friday, November 16, 2012 from 9 a.m. to 5 p.m. EST. All who wish to join the webcast must register by October 16, 2012. Registration instructions are found on the Federal Select Agent Program Web site, http:// www.selectagents.gov. DATES: Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\14SEN1.SGM 14SEN1 56846 Federal Register / Vol. 77, No. 179 / Friday, September 14, 2012 / Notices The webcast will be broadcast from the Centers for Disease Control and Prevention facility, 1600 Clifton Rd. NE., Atlanta, GA 30329. FOR FURTHER INFORMATION CONTACT: CDC: LCDR. Jacinta Smith, Division of Select Agents and Toxins, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., MS A–46, Atlanta, GA 30333; lrsat@cdc.gov. APHIS: Dr. Lidia Carrera, APHIS Select Agent Program, APHIS, 4700 River Road, Unit 2, Riverdale, MD 20737; Lidia.Carrera@aphis.usda.gov SUPPLEMENTARY INFORMATION: Title II of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002, ‘‘Enhancing Controls on Dangerous Biological Agents and Toxins’’ (sections 201 through 231), provides for the regulation of certain biological agents and toxins by the Department of Health and Human Services (subtitle A, sections 201–204) and the Department of Agriculture (subtitle B, sections 211–213). Additionally, the statute provides for interagency coordination between the two departments regarding overlap agents and toxins (subtitle C, section 221). For the Department of Health and Human Services(HHS), the Centers for Disease Control and Prevention (CDC) oversees entities that possess, use or transfer select agents and toxins that have the potential to pose a severe threat to public health and safety. The U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) has a parallel program that oversees entities that possess, use or transfer select agents that have the potential to pose a severe threat to animal or plant health, or to animal or plant products . These two programs constitute the Federal Select Agent Program. The Federal Bureau of Investigation’s (FBI) Criminal Justice Information Services conducts security risk assessments of (1) all individuals and nongovernmental entities that request to possess, use, or transfer select agents and toxins, (2) all individuals who need access to select agents and toxins. The webcast announced in this notice is an opportunity for the regulated community (i.e., registered entity responsible officials, alternate responsible officials, and entity owners) and other interested individuals to obtain specific regulatory guidance and information on standards concerning biosafety, biosecurity and incident response issues related to the Federal Select Agent Program. Representatives mstockstill on DSK4VPTVN1PROD with NOTICES ADDRESSES: VerDate Mar<15>2010 16:39 Sep 13, 2012 Jkt 226001 from HHS/CDC, USDA/APHIS, and the FBI will be present during the webcast to address questions and concerns from the web participants. Updates on the changes to the select agent regulations; occupational health, information and physical security; personnel suitability; FD–961 form, and changes to the APHIS/CDC Form 1 are among the issues that will be discussed. A question and answer session will take place after each topic. Registration instructions are found on the Federal Select Agent Program Web site http://www.selectagents.gov. Registration ends on October 16, 2012. This is a webcast only event and there will be no on-site participation at the HHS/CDC broadcast facility. Registration is required for participation. This is a 100% webcast; therefore, in person participation cannot be accommodated. Participants will be able to submit questions during the webcast at selectagentwkshp@cdc.gov. Closedcaptioning services will be provided during the webcast. Dated: September 10, 2012. Tanja Popovic, Deputy Associate Director for Science, Centers for Disease Control and Prevention. [FR Doc. 2012–22653 Filed 9–13–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2012–N–0937] Agency Information Collection Activities; Proposed Collection; Comment Request; Clinical Laboratory Improvement Amendments of 1988 Waiver Applications AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on collections of information associated with Clinical Laboratory Improvement SUMMARY: PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Amendments of 1988 waiver applications. Submit either electronic or written comments on the collection of information by November 13, 2012. ADDRESSES: Submit electronic comments on the collection of information to http:// www.regulations.gov. Submit written comments on the collection of information to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Daniel Gittleson, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50– 400B, Rockville, MD 20850, 301–796– 5156, Daniel.Gittleson@fda.hhs.gov. SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501–3520), Federal Agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. ‘‘Collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes Agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal Agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document. With respect to the following collection of information, FDA invites comments on these topics: (1) Whether the proposed collection of information is necessary for the proper performance of FDA’s functions, including whether the information will have practical utility; (2) the accuracy of FDA’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology. DATES: E:\FR\FM\14SEN1.SGM 14SEN1

Agencies

[Federal Register Volume 77, Number 179 (Friday, September 14, 2012)]
[Notices]
[Pages 56845-56846]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-22653]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Multi-Agency Informational Meeting Concerning Compliance With the 
Federal Select Agent Program; Public Webcast

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of public webcast.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) in the 
Department of Health and Human Services (HHS) announces the notice of a 
public webcast concerning compliance with the Federal Select Agent 
Program. The purpose of this notice is to notify all interested 
parties, including individuals and entities possessing, using, or 
transferring biological agents and toxins listed in 7 CFR 331.3, 9 CFR 
121.3 and 121.4, or 42 CFR 73.3 and 73.4, of the webcast. The webcast 
is organized by the U.S. Department of Agriculture's Animal and Plant 
Health Inspection Service (USDA/APHIS), the Department of Health and 
Human Services Centers for Disease Control and Prevention (HHS/CDC), 
and the Department of Justice's Federal Bureau of Investigation (FBI). 
Issues to be discussed include changes to the select agent regulations; 
occupational health, information and physical security; personnel 
suitability; Bioterrorism Security Risk Assessment Form (FD-961 form); 
and changes to the Application for Laboratory Registration for 
Possession, Use, and Transfer of Select Agents and Toxins (APHIS/CDC 
Form 1).

DATES: The webcast will be held on Friday, November 16, 2012 from 9 
a.m. to 5 p.m. EST. All who wish to join the webcast must register by 
October 16, 2012. Registration instructions are found on the Federal 
Select Agent Program Web site, http://www.selectagents.gov.

[[Page 56846]]


ADDRESSES: The webcast will be broadcast from the Centers for Disease 
Control and Prevention facility, 1600 Clifton Rd. NE., Atlanta, GA 
30329.

FOR FURTHER INFORMATION CONTACT: 
    CDC: LCDR. Jacinta Smith, Division of Select Agents and Toxins, 
Office of Public Health Preparedness and Response, Centers for Disease 
Control and Prevention, 1600 Clifton Road, NE., MS A-46, Atlanta, GA 
30333; lrsat@cdc.gov.
    APHIS: Dr. Lidia Carrera, APHIS Select Agent Program, APHIS, 4700 
River Road, Unit 2, Riverdale, MD 20737; Lidia.Carrera@aphis.usda.gov

SUPPLEMENTARY INFORMATION: Title II of the Public Health Security and 
Bioterrorism Preparedness and Response Act of 2002, ``Enhancing 
Controls on Dangerous Biological Agents and Toxins'' (sections 201 
through 231), provides for the regulation of certain biological agents 
and toxins by the Department of Health and Human Services (subtitle A, 
sections 201-204) and the Department of Agriculture (subtitle B, 
sections 211-213). Additionally, the statute provides for interagency 
coordination between the two departments regarding overlap agents and 
toxins (subtitle C, section 221). For the Department of Health and 
Human Services(HHS), the Centers for Disease Control and Prevention 
(CDC) oversees entities that possess, use or transfer select agents and 
toxins that have the potential to pose a severe threat to public health 
and safety. The U.S. Department of Agriculture's (USDA) Animal and 
Plant Health Inspection Service (APHIS) has a parallel program that 
oversees entities that possess, use or transfer select agents that have 
the potential to pose a severe threat to animal or plant health, or to 
animal or plant products . These two programs constitute the Federal 
Select Agent Program. The Federal Bureau of Investigation's (FBI) 
Criminal Justice Information Services conducts security risk 
assessments of (1) all individuals and nongovernmental entities that 
request to possess, use, or transfer select agents and toxins, (2) all 
individuals who need access to select agents and toxins.
    The webcast announced in this notice is an opportunity for the 
regulated community (i.e., registered entity responsible officials, 
alternate responsible officials, and entity owners) and other 
interested individuals to obtain specific regulatory guidance and 
information on standards concerning biosafety, biosecurity and incident 
response issues related to the Federal Select Agent Program. 
Representatives from HHS/CDC, USDA/APHIS, and the FBI will be present 
during the webcast to address questions and concerns from the web 
participants.
    Updates on the changes to the select agent regulations; 
occupational health, information and physical security; personnel 
suitability; FD-961 form, and changes to the APHIS/CDC Form 1 are among 
the issues that will be discussed. A question and answer session will 
take place after each topic.
    Registration instructions are found on the Federal Select Agent 
Program Web site http://www.selectagents.gov. Registration ends on 
October 16, 2012. This is a webcast only event and there will be no on-
site participation at the HHS/CDC broadcast facility. Registration is 
required for participation. This is a 100% webcast; therefore, in 
person participation cannot be accommodated.
    Participants will be able to submit questions during the webcast at 
selectagentwkshp@cdc.gov. Closed-captioning services will be provided 
during the webcast.

    Dated: September 10, 2012.
Tanja Popovic,
Deputy Associate Director for Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2012-22653 Filed 9-13-12; 8:45 am]
BILLING CODE 4163-18-P